topical lidocaine	intravenous lidocaine	Cough	1525	1667	Cough (primary outcome) was significantly more frequent among those with topical compared with intravenous lidocaine (46% vs. 26%; P = 0.004).
topical lidocaine	intravenous lidocaine	apnea, laryngospasm, bronchospasm, vomiting	14425	14546	Other variables including apnea, laryngospasm, bronchospasm, desaturation, and vomiting were not statistically different.
topical lidocaine	intravenous lidocaine	Cough	14302	14424	Incidence of cough in the pediatric patients was statistically higher in those who received topical lidocaine (P = 0.004).
